Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 14/20 | 0.50 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.48 |
| ▸ | TGM2 | P21980 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11780046 | 0.90 | EPHX1 (0.66) | ACHEEPHX1 | |
| SCHEMBL5077588 | 0.90 | EPHX1 (0.66) | ACHEEPHX1 | |
| SCHEMBL25272627 | 0.90 | EPHX1 (0.66) | ACHEEPHX1 | |
| SCHEMBL28422782 | 0.90 | EPHX1 (0.66) | ACHEEPHX1 | |
| SCHEMBL1416152 | 0.86 | ACHE (0.50) | ACHEEPHX1TDP1 | |
| SCHEMBL1160484 | 0.85 | ACHE (0.70) | ACHEEPHX1 | |
| SCHEMBL4245704 | 0.81 | ACHE (0.40) | ACHEEPHX1TGM2KDM4EMAPK1 | |
| SCHEMBL1416054 | 0.81 | — | — | |
| SCHEMBL1415970 | 0.79 | — | — | |
| SCHEMBL7790876 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11866590-B2 | Diisocyanate-based radical polymerizable silane coupling compound having an urethane bond | KABUSHIKI KAISHA SHOFU (JP) | 2024-01-09 | — | — | US | disclosed |
| US-20210395532-A1 | DIISOCYANATE-BASED RADICAL POLYMERIZABLE SILANE COUPLING COMPOUND HAVING AN URETHANE BOND | KABUSHIKI KAISHA SHOFU (JP) | 2021-12-23 | — | — | US | disclosed |
| US-20210122770-A1 | SILANE COUPLING COMPOUNDS AND MEDICAL AND/OR DENTAL CURABLE COMPOSITIONS COMPRISING THE SAME | KABUSHIKI KAISHA SHOFU (JP) | 2021-04-29 | — | — | US | disclosed |
| US-10975229-B2 | Silane coupling compounds and medical and/or dental curable compositions comprising the same | KABUSHIKI KAISHA SHOFU (JP) | 2021-04-13 | — | — | US | disclosed |
| US-20190300552-A1 | SILANE COUPLING COMPOUNDS AND MEDICAL AND/OR DENTAL CURABLE COMPOSITIONS COMPRISING THE SAME | KABUSHIKI KAISHA SHOFU (JP) | 2019-10-03 | — | — | US | disclosed |
| US-9237990-B2 | Polymerizable isocyanurate monomers and dental compositions | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2016-01-19 | — | — | US | disclosed |
| US-20130012614-A1 | POLYMERIZABLE ISOCYANURATE MONOMERS AND DENTAL COMPOSITIONS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2013-01-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130012614-A1 | POLYMERIZABLE ISOCYANURATE MONOMERS AND DENTAL COMPOSITIONS | ETV6, PCMT1, MLLT1 | ACHE 3256/4885EPHX1 1016/4885TGM2 229/4885 |
| US-20210122770-A1 | SILANE COUPLING COMPOUNDS AND MEDICAL AND/OR DENTAL CURABLE COMPOSITIONS COMPRISING THE SAME | SMCHD1, CAD, EPM2A | ACHE 3391/4885EPHX1 1853/4885TGM2 1425/4885 |
| US-11866590-B2 | Diisocyanate-based radical polymerizable silane coupling compound having an urethane bond | CAD, DCLRE1A, STIM1 | ACHE 2993/4885EPHX1 2796/4885TGM2 1486/4885 |
| US-10975229-B2 | Silane coupling compounds and medical and/or dental curable compositions comprising the same | SMCHD1, CAD, EPM2A | ACHE 3391/4885EPHX1 1853/4885TGM2 1425/4885 |
| US-20190300552-A1 | SILANE COUPLING COMPOUNDS AND MEDICAL AND/OR DENTAL CURABLE COMPOSITIONS COMPRISING THE SAME | SMCHD1, CAD, EPM2A | ACHE 3391/4885EPHX1 1853/4885TGM2 1425/4885 |
| US-20210395532-A1 | DIISOCYANATE-BASED RADICAL POLYMERIZABLE SILANE COUPLING COMPOUND HAVING AN URETHANE BOND | CAD, DCLRE1A, STIM1 | ACHE 2993/4885EPHX1 2796/4885TGM2 1486/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.